# Jbc Corp – FDA Inspection, May 24, 2019

Source: https://www.keypedia.com/records/fda_inspections/jbc-corp/b4b57eb6-1726-4b40-9e2b-ab6ea2a75a5d
Source feed: FDA_Inspections

> FDA inspection 1090644 of Jbc Corp, May 24, 2019. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1090644
- Company Name: Jbc Corp
- Inspection Date: 2019-05-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 5

## Related Documents

- [FDA Inspection 1081474 - 2019-02-08](https://www.keypedia.com/records/fda_inspections/jbc-corp/63472ddd-e2b3-4fa2-87dd-114d3c601e69)
- [FDA Inspection 794698 - 2012-08-28](https://www.keypedia.com/records/fda_inspections/jbc-corp/bfd87d2d-6077-40c6-a915-a2eadc12a74a)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/david-a-oluwo/209d60bd-27d8-487b-8249-1c6e44fcc317)

Company: https://www.keypedia.com/companies/jbc-corp/beced889-92ee-45ae-86a9-0e7d0decc75e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
